Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024)
Atara Biotherapeutics (ATRA) posted Inventory Average of $12.3 million for Q4 2024, down 24.73% on a QoQ basis from $16.4 million in Q3 2024, and up 51.16% year-over-year from $8.1 million in Q1 2024.
Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024) Analysis & Trends
Atara Biotherapeutics' Inventory Average history runs 2 years deep, the most recent figure standing at $12.3 million for Q4 2024.
- Quarterly Inventory Average rose 51.16% year-over-year to $12.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $12.3 million (up 51.16% YoY) and the FY2024 annual result came in at $10.2 million, up 80.31% from the prior year.
- Inventory Average was $12.3 million for Q4 2024 at Atara Biotherapeutics, down from $16.4 million in the prior quarter.
- Across five years, Inventory Average topped out at $17.4 million in Q2 2024 and bottomed at $3.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.32 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.46 Mn |